Abstract | BACKGROUND: METHODS: The polymorphisms of HLA class I and II antigens in ESRD patients and a healthy control group were retrospectively analyzed. The information of 141 ESRD patients was obtained from the medical record of the Keelung branch of Chang Gung Memorial Hospital and was compared to the HLA type of a control group comprized of 190 healthy unrelated Taiwanese from one of our previous studies. In order to standardize the HLA designation of prior low-resolution typings with the more advanced DNA based typings, all HLA-A, -B and -DR were analyzed using a low resolution serologic equivalent. RESULTS: The current work suggests that HLA-DR3 (odds ratio = 1.91, 95 % CI = 1.098-3.324, P = 0.024, Pc = 0.312) and HLA-DR11 (odds ratio = 2.06, 95 % CI = 1.133-3.761, P = 0.021, Pc = 0.273) may represent susceptibility risk factors for the development of ESRD in Taiwanese individuals. On the other hand, HLA-DR8 (odds ratio = 0.47, 95 % CI = 0.236-0.920, p = 0.027. Pc = 0.351) may be a protective factor. HLA-A and -B antigens did not show any contribution of progression to ESRD. However, we note that the significance of all these findings is lost when the results are corrected for multiple comparisons according to Bonferroni. Further investigation with a larger group of patients and control is needed to resolve this issue. CONCLUSIONS: HLA typing might be a useful clinical method for screening patients with high risk of progression to ESRD.
|
Authors | Ciou-Sia Dai, Chen-Chung Chu, Shin-Fan Chen, Chiao-Yin Sun, Marie Lin, Chin-Chan Lee |
Journal | BMC nephrology
(BMC Nephrol)
Vol. 16
Pg. 177
(Oct 30 2015)
ISSN: 1471-2369 [Electronic] England |
PMID | 26518904
(Publication Type: Journal Article)
|
Chemical References |
- Genetic Markers
- HLA Antigens
|
Topics |
- Adult
- Base Sequence
- Female
- Genetic Association Studies
- Genetic Markers
(genetics)
- Genetic Predisposition to Disease
(epidemiology, genetics)
- HLA Antigens
(genetics)
- Histocompatibility Testing
(statistics & numerical data)
- Humans
- Kidney Failure, Chronic
(epidemiology, genetics)
- Male
- Molecular Sequence Data
- Polymorphism, Single Nucleotide
(genetics)
- Prevalence
- Reproducibility of Results
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Sensitivity and Specificity
- Taiwan
(epidemiology)
|